Chairs: S Ferrari

Members: : B Abrahamsen, K Akesson, N Al-Daghri, E Biver, M Chakhthoura, M Chandran, T Chevalley, R Eastell, G El Hajj Fuleihan, CC Glüer, G Holzer, B Josse, D Kendler, N Lane, B Larijani, W Leslie, P Makras, C Meier, A Mithal, N Napoli, JY Reginster, A Suzuki, T Nickolas

To give guidance on the diagnosis and management of osteoporosis in the context of diabetes.

Guidelines for diagnosis and management of bone fragility in diabetes

1. Meier, C., et al., (2023). Biochemical Markers of Bone Fragility in Patients With Diabetes. The Journal of Clinical Endocrinology & Metabolism, dgad255. https://doi.org/10.1210/clinem/dgad255
2. Ferrari, S., et al. Bone microstructure and TBS in diabetes: what have we learned? A narrative review. Osteoporos Int, 2025. 36(7): p. 1115-1128
3. Ferrari SL, et al., on behalf of the Bone and Diabetes Working Group of IOF. Diagnosis and Management of Bone Fragility in Diabetes: An Emerging Challenge – A Short Review. Journal of Diabetes Management and Metabolism, 2020. JDMM-10008
4. Ferrari, S.L., et al., Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int, 2018. 29(12): p. 2585-2596.
5. Napoli, N., et al., Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol, 2017. 13(4): p. 208-219.
6. Hough, F.S., et al., MECHANISMS IN ENDOCRINOLOGY: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus. Eur J Endocrinol, 2016. 174(4): p. R127-38.